Trending...
- Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
- Tidy-Up Tacoma Teams Up with Community Partners for Citywide Cleanup Event September 19
- Defense & Space Strategy Strengthens as New Leadership Builds on NASA Results and Expanding Multi-Orbit Opportunities for Ascent Solar Technologies
Harnessing the Swarm: UVify's Leadership in Swarm Drone Technology Promises a Revolution in UAV Applications, Highlighting Efficiency, Scalability, and a New Era of Aerial Coordination at the 2023 Commercial UAV Expo.
SAN FRANCISCO - Washingtoner -- UVify, the creators of the IFO, the world's leading swarm light show drone with 90% of the North American market and 80% globally, is set to make waves at the 2023 Commercial UAV Expo from September 5-7 at Caesars Forum, Las Vegas. In addition to their swarm technology dominance, UVify is also recognized for its prowess in autonomous drone developer platforms, including the IFO-S and OMEGA. UVify's Chief Operating Officer, Robert Cheek, will present on "Drone Pilot Opportunities and Operations" on September 6, offering deep insights into the rapidly evolving swarm technologies.
Geoff Archer, spokesperson for UVify, remarked, "Mr. Cheek's presentation embodies UVify's relentless innovation and leadership in the UAV space. His expert insights combined with our market-leading products ensure this session is not to be missed."
More on Washingtoner
Event Highlights:
Archer further noted, "From its inception in 2015, UVify has been a beacon of innovation in the drone sector. Our multiple accolades, including those from CES, speak volumes about our commitment to excellence and innovation. This Expo is a testament to our continual evolution."
About UVify: Established in 2015, UVify's footprint in the UAV industry is unparalleled. With the IFO leading the swarm light show domain and the advanced IFO-S and OMEGA autonomous drone platforms, UVify's commitment to innovation shines brightly.
Event Details:
For media inquiries or to schedule interviews with UVify representatives during the Expo, please contact Geoff Archer.
Geoff Archer, spokesperson for UVify, remarked, "Mr. Cheek's presentation embodies UVify's relentless innovation and leadership in the UAV space. His expert insights combined with our market-leading products ensure this session is not to be missed."
More on Washingtoner
- Century Fasteners de Mexico Exhibiting at the 2026 Automotive & Aerospace Nearshoring Summit
- Spokane: Funding Available for Tourism and Culture Investment Grants
- Retell AI White Label Platform for Agencies Launched by VoiceAIWrapper, With Branded Client Portals and No Per-Minute Markup
- FOCUS Names Mark Phillips Senior Vice President of Business Development
- Notaron Expands Online Notarization Access Following Wisconsin Approval
Event Highlights:
- Deep Dive into Swarm Technology: Unveiling the potential and mechanics of the globally recognized IFO series.
- Engagement & Interactivity: Attendees are presented with a unique opportunity to directly interact with Mr. Cheek, fostering an atmosphere of learning and collaboration.
- UVify Showcase: Booth 449 will spotlight UVify's groundbreaking products, including the unmatched IFO, IFO-S, and OMEGA.
Archer further noted, "From its inception in 2015, UVify has been a beacon of innovation in the drone sector. Our multiple accolades, including those from CES, speak volumes about our commitment to excellence and innovation. This Expo is a testament to our continual evolution."
About UVify: Established in 2015, UVify's footprint in the UAV industry is unparalleled. With the IFO leading the swarm light show domain and the advanced IFO-S and OMEGA autonomous drone platforms, UVify's commitment to innovation shines brightly.
Event Details:
- Dates: September 5-7, 2023
- Presentation by Robert Cheek: September 6, 12:00 PM - 12:30 PM PDT
- Venue: Exhibit Hall Theater, Caesars Forum, Las Vegas, NV
- Booth: 449
- UVify's Website: www.uvify.com
For media inquiries or to schedule interviews with UVify representatives during the Expo, please contact Geoff Archer.
Source: UVify
0 Comments
Latest on Washingtoner
- Lawsuit Alleges American Deli Food Caused Severe Illness, Acute Kidney Failure, And Eight-day Hospitalization
- FBI/DoW plot uncovered to hurt Trump/Vance through encouraged "widespread" cybersecurity breaches and racketeering theft of $80m in USDA payments
- City of Tacoma Aligns Parking Rates and Facilities for Downtown Parking Network Effective October 13
- Bettingbladet releases H1 2026 report on the Swedish online gambling market
- Garage door installation or repair in Minnesota? Which makes more sense for your family?
- Tacoma: Application for 2027 Community Arts Projects Funding Now Available
- Haven Treatment Center Now In-Network Partnership with ComPsych, Expanding Access to Youth Health
- Tacoma: OMWBE Certification 201 Workshop on September 28
- Super Rooter Expands to 190 Plumbing, Sewer, and Drain Service Locations Across the United States
- European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP
- VICTURY Sports Announces Formation of Youth Sports League Built on the Official, Patented, and Award-Winning Keepy Uppy® Ball
- Congressman Chuck Edwards (NC-11) Presents ReadyCommunities Partnership 2026 National Service Award to Local Businessman / US Air Force Veteran
- Cress Creeks Farm Opens Fall Corn Maze and Baby Lamb Hayride Experience in Ellijay, Georgia
- Allstream Energy Partners Nominated in Multiple Categories for Fast Company's Best Workplaces for Innovators
- Pebble Photo Booths Brings Modern Photo Experiences to Vancouver, Washington
- Spokane: Flags at Half-Staff in Remembrance of 9/11 Victims
- Haven Treatment Center Now In-Network with First Choice, Expanding Access to Youth Health
- Kerri Lawless Introduces New Home-Selling Option for Local Homeowners
- FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
- Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate





